Jesús García-Donás
HM Hospitales(ES)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments, Renal and related cancers, Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics
Most-Cited Works
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma(2019)1,342 cited
- → Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer(2019)912 cited
- → Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer(2017)391 cited
- → Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study(2011)220 cited
- → Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study(2022)165 cited
- → A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families(2015)161 cited
- → Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)(2015)155 cited
- → Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis(2013)134 cited
- → Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.(2019)133 cited